Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients

Table 3 Characteristics of DLR of HBV reactivators with patterns of protracted/unresolved (A) and multiple reactivations (B)

Reactivation pattern	Outcome	Cause of death	Type of DLR	Ratio of A/G ratio	Ratio of INR of PT
A	Died	Hepatic failure	H	0.62	3.88
A	Died	Hepatic failure	H	1	1.27
A	Died	Cancer progression	N	0.86	NA
A	Died	Cancer progression	N	0.6	1.38
B	Alive	NA	N	NA	NA
B	Died	Hepatic failure/cancer progression	H	NA	1.36

H: HBV reactivation related hepatic failure; N: newly developed coarse liver echotexture; NA: not available.